Aihara H, Ogawa H, Kasuya A, Yoshida M, Suzuki-Kusaba M, Hisa H, Satoh S
Department of Pharmacology, Pharmaceutical Institute, Tohoku University, Aobayama, Sendai, Japan.
Eur J Pharmacol. 1999 May 28;373(1):35-40. doi: 10.1016/s0014-2999(99)00266-6.
We examined the hypotensive effect of enalapril in relation to the local renin-angiotensin system of the kidney in spontaneously hypertensive rats (SHR). Oral administration of enalapril for 7 days decreased mean arterial blood pressure and renal tissue angiotensin II concentration without affecting plasma angiotensin II concentration in SHR. The enalapril treatment did not affect maximum binding of angiotensin II to renal tubules and glomeruli in SHR. In normotensive Wistar-Kyoto rats, no significant changes in mean arterial blood pressure, renal and plasma angiotensin levels were observed with enalapril treatment. Direct infusion of enalapril into the renal medullary interstitium decreased mean arterial blood pressure in association with the reduction of renal tissue angiotensin II concentration without changes in plasma angiotensin II concentration in SHR. These observations suggest that the inhibition of angiotensin conversion in the kidney is important for the hypotensive action of enalapril.
我们研究了依那普利对自发性高血压大鼠(SHR)肾脏局部肾素-血管紧张素系统的降压作用。在SHR中,口服依那普利7天可降低平均动脉血压和肾组织血管紧张素II浓度,而不影响血浆血管紧张素II浓度。依那普利治疗不影响SHR中血管紧张素II与肾小管和肾小球的最大结合。在正常血压的Wistar-Kyoto大鼠中,依那普利治疗未观察到平均动脉血压、肾和血浆血管紧张素水平的显著变化。将依那普利直接注入肾髓质间质可降低平均动脉血压,同时降低肾组织血管紧张素II浓度,而SHR的血浆血管紧张素II浓度无变化。这些观察结果表明,肾脏中血管紧张素转化的抑制对依那普利的降压作用很重要。